TG Therapeutics Stock Price (NASDAQ:TGTX)

Add to My Stocks
$10.95 $0.1 (0.92%) TGTX stock closing price Aug 21, 2017 (Closing)
Prev Close* : $10.85
Market Cap:
$746.87M
Day Low: $10.55
52 Week Low: $4.10
Open: $10.85
Volume: 898261
Day High: $11
52 Week High: $15.35
Dividend:
N/A

Latest Stock Market News

Latest Articles

TG Therapeutics News - From Partners

TGTX Stockcharts

View TGTX PE ratio, PS ratio stocks charts and compare with peers.
TGTX Chart
Note: Compare TG Therapeutics stock price history with the index and industry peers.

TG Therapeutics Valuation

PS ratio (
price to sales ratio
)
4330.73
PB ratio (
price to book ratio
)
9.89

TG Therapeutics Financial Ratios

Receivables Turnover
1.63

TGTX Industry Peers

Company Price Change (%)
Nordion (NDZ)12.990.01 (0.08%)
Atricure (ATRC)22.140.23 (1.03%)
Infinity Pharma (INFI)0.950.05 (5%)
Abbvie (ABBV)70.70.74 (1.06%)
Johnson & Johnson (JNJ)133.450.82 (0.62%)
Fortress Biotech (FBIO)4.450.2 (4.71%)
Gilead Sciences (GILD)72.60.49 (0.68%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Conatus Pharma (CNAT)5.150.14 (2.79%)
Enzymotec (ENZY)10.80.25 (2.37%)
Insulet (PODD)55.7850.96 (1.75%)
Fonar (FONR)26.650.4 (1.52%)
SurModics (SRDX)25.40.35 (1.4%)
Chimerix (CMRX)4.410.06 (1.38%)
Oramed Pharma (ORMP)8.220.11 (1.36%)
Top gainers from Medical Products industry
* As of Aug 21, 2017
CompanyPriceChange (%)
Omeros (OMER)20.81.23 (5.58%)
Cardiovascular Systems (CSII)29.020.63 (2.12%)
Utah Medical Products (UTMD)71.550.95 (1.31%)
Insys Therapeutics (INSY)9.050.12 (1.31%)
GW Pharma (GWPH)98.751.17 (1.17%)
AtriCure (ATRC)22.140.23 (1.03%)
Cerus (CERS)2.480.02 (0.8%)
Top losers from Medical Products industry
* As of Aug 21, 2017

TG Therapeutics Inc Stock News - Partner Headlines

TG Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues0.15M0.15M0.15M0.15M0.01M
Net Income-78.25M-62.94M-55.78M-20.47M-18.07M
Total Operating Expense79.11M63.32M55.86M23.11M26.91M
View TG Therapeutics income statement
balance sheet20162015201420132012
Total Assets54.78M113.47M86.74M48.11M22.07M
Total Liabilities18.91M11.89M6.64M8.05M6.52M
Shareholders Equity35.86M101.57M80.1M40.05M15.55M
View TG Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities8.77M2.06M-6.04M4.15M0.7M
Net Cash from (used by) Operating Activities-61.59M-44.69M-35.05M-10.82M-5.18M
Increase (Decrease) in Prop Plant And Equipment-0.34M-0.04M-0.01M-0.01M-
View TG Therapeutics cash flow statement

TG Therapeutics Stock Message Board

As of last trading day, TG Therapeutics stock price was 10.85. The total market value as denoted by 757.2M for TG Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing TG Therapeutics stock analysis.

The terms stocks and shares mean the same thing. For Ex: TG Therapeutics stock price and TG Therapeutics share price mean the same thing. The volume number in TG Therapeutics stock quote data shows the number of shares traded. For Ex: 889366 TG Therapeutics shares were traded as of last trading day, as seen from TG Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of TGTX, view TG Therapeutics stock price history.